These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11791689)

  • 41. Comparison of mometasone furoate dry powder inhaler and fluticasone propionate dry powder inhaler in patients with moderate to severe persistent asthma requiring high-dose inhaled corticosteroid therapy: findings from a noninferiority trial.
    Harnest U; Price D; Howes T; Sussman G
    J Asthma; 2008 Apr; 45(3):215-20. PubMed ID: 18415829
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery.
    Liu S; Watts AB; Du J; Bui A; Hengsawas S; Peters JI; Williams RO
    Eur J Pharm Biopharm; 2015 Oct; 96():132-42. PubMed ID: 26220015
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The efficacy and safety of mometasone furoate delivered via a dry powder inhaler for the treatment of asthma.
    Meltzer EO; Wenzel S
    J Asthma; 2006 Dec; 43(10):765-72. PubMed ID: 17169829
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
    Fish JE; Karpel JP; Craig TJ; Bensch GW; Noonan M; Webb DR; Silverman B; Schenkel EJ; Rooklin AR; Ramsdell JW; Nathan R; Leflein JG; Grossman J; Graft DF; Gower RG; Garay SM; Frigas E; Degraff AC; Bronsky EA; Bernstein DI; Berger W; Shneyer L; Nolop KB; Harrison JE
    J Allergy Clin Immunol; 2000 Nov; 106(5):852-60. PubMed ID: 11080706
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of mometasone furoate given once daily in the evening on lung function and symptom control in persistent asthma.
    Karpel JP; Busse WW; Noonan MJ; Monahan ME; Lutsky B; Staudinger H
    Ann Pharmacother; 2005 Dec; 39(12):1977-83. PubMed ID: 16264062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products.
    Ross DL; Schultz RK
    J Aerosol Med; 1996; 9(2):215-26. PubMed ID: 10163351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro aerosol performance and dose uniformity between the Foradile Aerolizer and the Oxis Turbuhaler.
    Chew NY; Chan HK
    J Aerosol Med; 2001; 14(4):495-501. PubMed ID: 11791690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of mometasone furoate delivered via two dry powder inhalers.
    Vaidya S; Ziegler D; Tanase AM; Malmqvist U; Kanniess F; Hederer B; Hosoe M
    Pulm Pharmacol Ther; 2021 Oct; 70():102019. PubMed ID: 33771722
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Once-daily evening administration of mometasone furoate in asthma treatment initiation.
    Bensch GW; Prenner B; Berkowitz R; Galant S; Ramsdell J; Lutsky B
    Ann Allergy Asthma Immunol; 2006 Apr; 96(4):533-40. PubMed ID: 16680923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mometasone furoate in children with mild to moderate persistent asthma: a review of the evidence.
    Milgrom H
    Paediatr Drugs; 2010 Aug; 12(4):213-21. PubMed ID: 20593906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The clinical relevance of dry powder inhaler performance for drug delivery.
    Demoly P; Hagedoorn P; de Boer AH; Frijlink HW
    Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Air classifier technology (ACT) in dry powder inhalation Part 4. Performance of air classifier technology in the Novolizer multi-dose dry powder inhaler.
    de Boer AH; Hagedoorn P; Gjaltema D; Goede J; Frijlink HW
    Int J Pharm; 2006 Mar; 310(1-2):81-9. PubMed ID: 16442246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Mometasone furoate: a corticosteroid that simplifies asthma management].
    Mihălţan F; Ulmeanu R
    Pneumologia; 2001; 50(4):261-4. PubMed ID: 11977504
    [No Abstract]   [Full Text] [Related]  

  • 54. Lung Delivery of Indacaterol and Mometasone Furoate Following Inhalation of QMF149 in Healthy Volunteers.
    Vaidya SS; Khindri S; Maahs S; Machineni S; Hara H; Juan A; Kaiser G
    Clin Pharmacol Drug Dev; 2016 Jul; 5(4):285-95. PubMed ID: 27310329
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Adrenal suppression with dry powder formulations of fluticasone propionate and mometasone furoate.
    Fardon TC; Lee DK; Haggart K; McFarlane LC; Lipworth BJ
    Am J Respir Crit Care Med; 2004 Nov; 170(9):960-6. PubMed ID: 15184207
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy, safety, and tolerability of mometasone furoate in adult Japanese patients with mild asthma: open-label clinical trial findings.
    Tohda Y; Miyamoto T
    Curr Med Res Opin; 2010 Jan; 26(1):203-12. PubMed ID: 19921960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W; Dahl R; Ringdal N; Zetterstrom O; van den Elshout FJ; Laitinen LA
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of particle properties in pharmaceutical powder inhalation formulations.
    Chew NY; Chan HK
    J Aerosol Med; 2002; 15(3):325-30. PubMed ID: 12396421
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.
    Duddu SP; Sisk SA; Walter YH; Tarara TE; Trimble KR; Clark AR; Eldon MA; Elton RC; Pickford M; Hirst PH; Newman SP; Weers JG
    Pharm Res; 2002 May; 19(5):689-95. PubMed ID: 12069174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adherence and asthma control with mometasone furoate versus fluticasone propionate in adolescents and young adults with mild asthma.
    Friedman HS; Navaratnam P; McLaughlin J
    J Asthma; 2010 Nov; 47(9):994-1000. PubMed ID: 20831468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.